Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€176.92
03.08.22
€190.00
03.08.23
-6.34%
03.08.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Future proof or reliable business model
buy
iBio Inc.

Start price
Target price
Perf. (%)
€6.24
03.08.22
€5.00
03.08.23
-75.96%
13.10.22

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€2.12
03.08.22
€2.60
03.08.23
-11.19%
20.09.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.39
03.08.22
€2.80
03.08.23
-14.19%
20.09.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.91
03.08.22
€3.30
03.08.23
-12.37%
13.10.22

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€49.24
31.07.22
€50.00
31.07.23
-31.05%
22.05.23

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Bayer AG

Start price
Target price
Perf. (%)
€56.99
29.07.22
-
29.08.22
3.00%
04.08.22

buy
Biofrontera AG

Start price
Target price
Perf. (%)
€1.22
29.07.22
-
29.07.23
-31.85%
30.07.23

buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€157.25
29.07.22
€200.00
29.07.23
14.87%
30.07.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€34.89
29.07.22
-
29.07.23
-26.25%
29.07.23

buy
Nanorepro AG

Start price
Target price
Perf. (%)
€3.97
27.07.22
€15.00
27.08.22
-14.12%
28.08.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Very high dividend yield expected
Top 10 in its market
buy
Medtronic plc

Start price
Target price
Perf. (%)
€91.39
27.07.22
€100.00
27.07.23
-11.48%
28.07.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€44.85
27.07.22
€60.00
27.07.23
5.35%
27.07.23

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Innovative
High dividend yield expected
Stratec SE

Start price
Target price
Perf. (%)
€85.00
26.07.22
€66.00
26.07.23
4.94%
06.08.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
US Physical Therapy Inc.

Start price
Target price
Perf. (%)
€122.00
26.07.22
-
26.07.23
-9.84%
26.07.23

buy
Tonix Pharmaceuticals Holding Corp.

Start price
Target price
Perf. (%)
€8.56
25.07.22
€12.50
25.07.23
26.95%
26.07.22

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Little innovation
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€9.55
25.07.22
€20.00
31.12.24
-75.71%
08.05.23

Could be very worthwhile Investment >20% year
buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€154.40
23.07.22
€170.00
23.08.22
5.63%
11.08.22

Could be very worthwhile Investment >20% year
Innovative
Sustainability is important
Small cyclical dependencies
buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€418.20
22.07.22
€550.00
22.07.23
-23.00%
30.05.23

Valneva SE

Start price
Target price
Perf. (%)
€9.82
21.07.22
-
21.07.23
-30.16%
22.07.23

Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
buy
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.37
21.07.22
€5.30
21.07.23
-21.42%
11.03.23

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.65
21.07.22
€0.60
21.07.23
-46.97%
19.11.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€49.74
20.07.22
€55.00
20.07.23
-33.55%
21.07.23

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
buy
GSK plc

Start price
Target price
Perf. (%)
€20.70
20.07.22
€20.00
20.07.23
-24.56%
13.10.22

High dividend yield expected
Good rating
Very small cyclical dependencies
Fair valuation
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.87
18.07.22
-
18.07.23
-9.48%
23.07.22

Could be worthwhile Investment >10% per year